Highlights
- Market Cap
- $51.85B
- Enterprise Value
- $59.08B
- EPS (TTM)
- $6.04
- PE Ratio
- 19.57
- PEG Ratio
- 2.19
- Total Revenue (TTM)
- $9.47B
- Gross Profit (TTM)
- $6.67B
- EBITDA (TTM)
- $4.09B
- Year Range
- $113.29 - $172.23
- Target Price
- $141.17
- ROA (TTM)
- 17.28%
- ROE (TTM)
- 80.25%
Share Price Chart
Loading graphics...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Zoetis Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Loading graphics...
Returns By Period
Zoetis Inc. (ZTS) has returned -5.65% so far this year and -27.16% over the past 12 months. Over the last ten years, ZTS has returned 11.03% per year, falling short of the S&P 500 Index benchmark, which averaged 12.16% annually.
Zoetis Inc.
- 1D
- 1.62%
- 1M
- -9.83%
- YTD
- -5.65%
- 6M
- -18.58%
- 1Y
- -27.16%
- 3Y*
- -9.76%
- 5Y*
- -4.72%
- 10Y*
- 11.03%
Benchmark (S&P 500 Index)
- 1D
- 2.91%
- 1M
- -5.09%
- YTD
- -4.63%
- 6M
- -2.39%
- 1Y
- 16.33%
- 3Y*
- 16.69%
- 5Y*
- 10.18%
- 10Y*
- 12.16%
Monthly Returns
Based on dividend-adjusted daily data since Feb 1, 2013, ZTS's average daily return is +0.06%, while the average monthly return is +1.12%. At this rate, your investment would double in approximately 5.2 years.
Historically, 62% of months were positive and 38% were negative. The best month was Nov 2014 with a return of +21.4%, while the worst month was Jan 2022 at -18.0%. The longest winning streak lasted 9 consecutive months, and the longest losing streak was 6 months.
On a daily basis, ZTS closed higher 52% of trading days. The best single day was Mar 24, 2020 with a return of +12.0%, while the worst single day was Mar 16, 2020 at -14.7%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -0.37% | 5.03% | -9.83% | -5.65% | |||||||||
| 2025 | 5.21% | -2.14% | -1.55% | -4.69% | 7.82% | -7.52% | -6.20% | 7.28% | -6.45% | -1.18% | -11.04% | -1.84% | -21.75% |
| 2024 | -4.63% | 5.60% | -14.68% | -5.62% | 6.48% | 2.24% | 4.10% | 1.92% | 6.48% | -8.28% | -1.97% | -7.03% | -16.63% |
| 2023 | 13.19% | 0.91% | -0.34% | 5.84% | -7.26% | 5.64% | 9.46% | 1.29% | -8.68% | -9.54% | 12.53% | 11.72% | 35.91% |
| 2022 | -18.00% | -3.07% | -2.61% | -5.85% | -3.57% | 0.56% | 6.40% | -14.25% | -5.26% | 1.90% | 2.23% | -4.92% | -39.51% |
| 2021 | -6.65% | 0.64% | 1.44% | 10.04% | 2.11% | 5.48% | 8.91% | 0.92% | -5.09% | 11.50% | 2.70% | 9.90% | 48.26% |
Benchmark Metrics
Zoetis Inc. has an annualized alpha of 3.11%, beta of 0.89, and R² of 0.35 versus S&P 500 Index. Calculated based on daily prices since February 04, 2013.
- This stock participates in less of S&P 500 Index's moves in both directions, but captures a larger share of gains (94.86%) than losses (94.56%) — typical of diversified or defensive assets.
- R² of 0.35 means the benchmark explains less than half of this stock's behavior — treat beta with caution or consider switching to a more representative benchmark.
- Alpha
- 3.11%
- Beta
- 0.89
- R²
- 0.35
- Upside Capture
- 94.86%
- Downside Capture
- 94.56%
Return for Risk
Risk / Return Rank
ZTS ranks 9 for risk / return — in the bottom 9% of stocks on our site. This means you're taking on significantly more risk than the returns justify. Consider whether the potential upside is worth the volatility, or explore alternatives with better risk / return profiles.
Return / Risk — by metrics
The table below present risk-adjusted performance metrics for Zoetis Inc. (ZTS) and compare them to a chosen benchmark (S&P 500 Index).
| ZTS | Benchmark | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.94 | 0.90 | -1.83 |
Sortino ratioReturn per unit of downside risk | -1.19 | 1.39 | -2.57 |
Omega ratioGain probability vs. loss probability | 0.84 | 1.21 | -0.37 |
Calmar ratioReturn relative to maximum drawdown | -0.81 | 1.40 | -2.21 |
Martin ratioReturn relative to average drawdown | -1.40 | 6.61 | -8.00 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Explore ZTS risk-adjusted metrics in detail
Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.
Dividends
Dividend History
Zoetis Inc. provided a 1.72% dividend yield over the last twelve months, with an annual payout of $2.03 per share. The company has been increasing its dividends for 12 consecutive years.
| Period | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend | $2.03 | $2.00 | $1.73 | $1.50 | $1.30 | $1.00 | $0.80 | $0.66 | $0.50 | $0.42 | $0.38 | $0.33 |
Dividend yield | 1.72% | 1.59% | 1.06% | 0.76% | 0.89% | 0.41% | 0.48% | 0.50% | 0.59% | 0.58% | 0.71% | 0.69% |
Monthly Dividends
The table displays the monthly dividend distributions for Zoetis Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | $0.53 | $0.00 | $0.00 | $0.53 | |||||||||
| 2025 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $0.50 | $0.00 | $0.00 | $2.00 |
| 2024 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $0.43 | $0.00 | $0.00 | $1.73 |
| 2023 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $0.38 | $0.00 | $0.00 | $1.50 |
| 2022 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $0.33 | $0.00 | $0.00 | $1.30 |
| 2021 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $0.25 | $0.00 | $0.00 | $1.00 |
Dividend Yield & Payout
Dividend Yield
Zoetis Inc. has a dividend yield of 1.72%, which is quite average when compared to the overall market.
Payout Ratio
Zoetis Inc. has a payout ratio of 33.26%, which is quite average when compared to the overall market. This suggests that Zoetis Inc. strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading graphics...
Worst Drawdowns
The table below displays the maximum drawdowns of the Zoetis Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Zoetis Inc. was 52.06%, occurring on Mar 27, 2026. The portfolio has not yet recovered.
The current Zoetis Inc. drawdown is 50.01%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -52.06% | Dec 30, 2021 | 1064 | Mar 27, 2026 | — | — | — |
| -36.07% | Feb 14, 2020 | 26 | Mar 23, 2020 | 81 | Jul 17, 2020 | 107 |
| -28.57% | Jun 26, 2015 | 158 | Feb 10, 2016 | 243 | Jan 27, 2017 | 401 |
| -17.32% | Mar 15, 2013 | 272 | Apr 11, 2014 | 89 | Aug 19, 2014 | 361 |
| -17.28% | Nov 5, 2020 | 81 | Mar 4, 2021 | 39 | Apr 29, 2021 | 120 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading graphics...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Zoetis Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Zoetis Inc. is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for ZTS, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/E ratio of 19.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PEG Ratio
The chart shows the Price/Earnings to Growth (PEG) ratio for ZTS compared to other companies in the Drug Manufacturers - Specialty & Generic industry. ZTS currently has a PEG ratio of 2.2. This PEG ratio is higher than the industry average, which may suggest the stock is overvalued relative to its expected earnings growth.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for ZTS relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/S ratio of 5.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for ZTS in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, ZTS has a P/B value of 15.6. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |